Stryker Corporation  

(Public, NYSE:SYK)   Watch this stock  
Find more results for SYK
-1.70 (-1.17%)
After Hours: 145.23 +1.18 (0.82%)
Jul 27, 5:14PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 142.97 - 145.99
52 week 106.48 - 148.15
Open 145.78
Vol / Avg. 0.00/1.06M
Mkt cap 53.84B
P/E 32.32
Div/yield 0.43/1.18
EPS 4.46
Shares 374.00M
Beta 0.79
Inst. own 76%
Jul 27, 2017
Q2 2017 Stryker Corp Earnings Call - Webcast
Jul 27, 2017
Q2 2017 Stryker Corp Earnings Release
Jun 14, 2017
Stryker Corp at Goldman Sachs Global Healthcare Conference - Webcast
May 17, 2017
Stryker Corp at Bank of America Merrill Lynch Healthcare Conference - Webcast
May 3, 2017
Stryker Corp Annual Shareholders Meeting - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '17) 2016
Net profit margin 15.03% 14.54%
Operating margin 18.75% 19.13%
EBITD margin - 27.50%
Return on average assets 8.70% 8.99%
Return on average equity 18.50% 18.24%
Employees 33,000 -
CDP Score - D


2825 Airview Blvd
PORTAGE, MI 49002-1802
United States - Map
+1-269-3892600 (Phone)
+1-269-3851062 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia


Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company's segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The MedSurg segment includes surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment, intensive care disposable products; reprocessed and remanufactured medical devices, and other related products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products. The Company's products include implants, which are used in joint replacement and trauma surgeries, and other products that are used in a range of medical specialties.

Officers and directors

Kevin A. Lobo Chairman of the Board, President, Chief Executive Officer
Age: 51
Bio & Compensation  - Reuters
Glenn S. Boehnlein Chief Financial Officer, Vice President
Age: 55
Bio & Compensation  - Reuters
Lonny J. Carpenter Group President - Global Quality and Business Operations
Age: 55
Bio & Compensation  - Reuters
David K. Floyd Group President - Orthopaedics
Age: 56
Bio & Compensation  - Reuters
Graham A. Mclean President, Asia-Pacific
Age: 52
Bio & Compensation  - Reuters
Timothy J. Scannell Group President - MedSurg and Neurotechnology
Age: 52
Bio & Compensation  - Reuters
M. Kathryn Fink Chief Human Resource Officer, Vice President
Age: 47
Bio & Compensation  - Reuters
William E. Berry Jr. Principal Accounting Officer, Vice President, Corporate Controller
Age: 51
Bio & Compensation  - Reuters
Bijoy S.N. Sagar Chief Information Officer, Vice President
Age: 48
Bio & Compensation  - Reuters
Katherine A. Owen Vice President - Strategy and Investor Relations
Age: 46
Bio & Compensation  - Reuters